Cargando…
PPARG Drives Molecular Networks as an Inhibitor for the Pathologic Development and Progression of Lung Adenocarcinoma
Previous studies showed that low PPARG expression was associated with poor prognosis of lung adenocarcinoma (LA) with limited mechanisms identified. We first conducted a large-scale literature-based data mining to identify potential molecular pathways where PPARG could exert influence on the patholo...
Autores principales: | Zhao, Min, Li, Xiaoyang, Zhang, Yunxiang, Zhu, Hongming, Han, Zhaoqing, Kang, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7199583/ https://www.ncbi.nlm.nih.gov/pubmed/32395124 http://dx.doi.org/10.1155/2020/6287468 |
Ejemplares similares
-
Differences of molecular events driving pathological and radiological progression of lung adenocarcinoma
por: Shang, Jun, et al.
Publicado: (2023) -
The Genetics of PPARG and the Skeleton
por: Ackert-Bicknell, Cheryl, et al.
Publicado: (2006) -
Role of PPARG in Chemosensitivity-Regulating Network for Hypopharyngeal Squamous Cell Carcinoma
por: Kong, Fanyong, et al.
Publicado: (2023) -
PPARG as therapeutic target for antifibrotic therapy
por: Ghallab, Ahmed, et al.
Publicado: (2020) -
The Impact of PPARD and PPARG Polymorphisms on Glioma Risk and Prognosis
por: Ding, Xiaoying, et al.
Publicado: (2020)